- Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 87:3336–3343.
- Bhattacharya R, Ye X, Wang R, Ling X, McManus M, Fan F, Boulbes D, Ellis L. 2016. Intra-crine VEGF signaling mediates the activity of pro-survival pathways in human colorectal cancer cells. Cancer. Res. 76:3014–3024.
- Broers J, Ramaekers F. 2014. The role of the nuclear lamina in cancer and apoptosis. Adv Exp Med Biol. 773:27–48.
- Chen M, Hung M. 2015. Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases. Febs J. 282:3693–3721.
- Chuvpilo S, Avots A, Berberich-Siebelt F, Glöckner J, Fischer C, Kerstan A, Escher C, Inashkina I, Hlubek F, Jankevics E. 1999. Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T-lymphocytes. J Immunol. 162:7294–7301.
- Fan F, Wey J, McCarty M, Belcheva A, Liu W, Bauer T, Somcio R, Wu Y, Hooper A, Hicklin D, et al. 2005. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene. 24:2647–2653.
- Kao W, Lin C, Lee L, Lee P, Hung C, Lin Y, Chen S, Ke F, Hwang J, Lee M. 2008. Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. Anticancer Res. 28:2109–2120.
- Lee T, Seng S, Sekine M, Hinton C, Fu Y, Avraham H, Avraham S. 2007. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally-expressed VEGFR1/FLT1. PLoS Med. 4:e186.
- Li YL, Zhao H, Ren XB, Li YL, Zhao H, Ren XB. 2016. Relationship of VEGF/VEGFR with immune and cancer cells: Staggering or forward? Cancer Biol Med. 13:206–214.
- Lockshin A, Giovanella B, de Ipolyi P, Williams L, Mendoza J, Yim S, Stehlin J. 1985. Exceptional lethality for nude mice of cells derived from a primary human melanoma. Cancer Res. 45:345–350.
- Owen L, Uehara H, Cahoon J, Huang W, Simonis J, Ambati B. 2012. Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization. PLoS One. 7:e33576.
- Price J, Sauder D, Fidler I. 1988. Tumorigenicity and metastatic behavior in nude mice of two human squamous cell carcinoma lines that differ in production of the cytokine ETAF/IL-1. J Invest Dermatol. 91:258–262.
- Tyrsin D. 2007. Autoregulation of NFATc1 gene. Dissertation for the completion of Doctorate in Natural Sciences (Bayerische Julius-Maximilians-Universitat, Wurzburg, 2007).
- Yegorov E, Moldaver M, Vishiniakova K, Terekhov S, Dashinimaev E, Cheglakov I, Toropygin I, Iarygin K, Chumakov P, Korochkin L. 2007. Enhanced control of proliferation in telomerized cells. Ontogenez. 38:105–119.
- Zhang Y, Lu Y, Ma L, Cao X, Xiao J, Chen J, Jiao S, Gao Y, Liu C, Duan Z, et al. 2014. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock. Immunity. 40:501–514.
- Zhang J, Silva T, Yarovinsky T, Manes TD, Tavakoli S, Nie L, Tellides G, Pober JS, Bender JR, Sadeghi MM. 2010. VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling. Circ Res. 107:408–417.
Journal of Immunotoxicology
Volume 16, 2019 - Issue 1
Open access
1,641
Views
1
CrossRef citations to date
0
Altmetric
Research Articles
Detection and quantification of VEGFR-1 in the nuclei of tumor cells by a new flow cytometry-based method
Ekaterina TyrsinaLaboratory of Experimental Diagnostics and Biotherapy of Tumors, Research Institute of Experimental Diagnostics and Therapy of Tumors, N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, RussiaCorrespondence[email protected] [email protected]
, Sergey NikulitskiyLaboratory of Experimental Diagnostics and Biotherapy of Tumors, Research Institute of Experimental Diagnostics and Therapy of Tumors, N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia
, Andrey InshakovLaboratory of Experimental Diagnostics and Biotherapy of Tumors, Research Institute of Experimental Diagnostics and Therapy of Tumors, N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia
, Oxana RyabayaLaboratory of Experimental Diagnostics and Biotherapy of Tumors, Research Institute of Experimental Diagnostics and Therapy of Tumors, N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia
& Dmitry TyrsinLaboratory of Experimental Diagnostics and Biotherapy of Tumors, Research Institute of Experimental Diagnostics and Therapy of Tumors, N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia
Pages 74-81
|
Received 15 Jan 2019, Accepted 15 Mar 2019, Published online: 15 Apr 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.